Patency of the ductus arteriosus in the newborn - Now you want it, now you don't

Pediatric Critical Care Medicine

Volumn 8, Issue 3, 2007, Pages 302-303

  Hansen, Thor Willy Ruud ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Heparin; Indomethacin; Patent ductus arteriosus; Peripherally inserted central venous catheter; Very low birthweight infant

Indexed keywords

HEPARIN; INDOMETACIN;

BLOOD FLOW; CLINICAL PRACTICE; CONCENTRATION (PARAMETERS); ECHOCARDIOGRAPHY; EDITORIAL; ELECTROCARDIOGRAPHY; HEALTH CARE POLICY; HUMAN; INTENSIVE CARE; LUNG BLOOD VESSEL; MORBIDITY; PATENT DUCTUS ARTERIOSUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; VASCULAR RESISTANCE;

DUCTUS ARTERIOSUS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PREGNANCY;

EID: 34248356327     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000262886.67502.2B     Document Type: Editorial

References (13)

1. Levin DL, Hyman AI, Heymann MA, et al: Fetal hypertension and the development of increased pulmonary vascular smooth muscle: A possible mechanism for persistent pulmonary hypertension of the newborn infant. J Pediatr 1978; 92:265-269
2. Morin FC III: Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res 1989; 25:245-250
3. Evans N: Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants. Adv Neonatal Care 2003; 3:168-177
4. Boucek MM, Mashburn C, Kunz E, et al: Ductal anatomy: A determinant of successful stenting in hypoplastic left heart syndrome. Pediatr Cardiol 2005; 26:200-205
5. Fowlie PW: Managing the baby with a patent ductus arteriosus. More questions than answers? Arch Dis Child Fetal Neonatal Ed 2005; 90:F190
6. Laughon MM, Simmons MA, Bose CL: Patency of the ductus arteriosus in the premature infant: Is it pathologic? Should it be treated? Curr Opin Pediatr 2004; 16:146-151
7. Van Overmeire B, Chemtob S: The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonat Med 2005; 10:177-184
8. Bancalari E, Claure N, Gonzalez A: Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 2005; 88:192-201
9. Ojala TH, Lehtonen L: A preliminary report - Heparin counteracts indomethacin effect on ductus arteriosus in very low birthweight infants. Pediatr Crit Care Med 2007; 8:258-260
10. Tangphao O, Chalon S, Moreno HJ Jr, et al: Heparin-induced vasodilation in human hand veins. Clin Pharmacol Ther 1999; 66:232-238
11. Tasatargil A, Golbasi I, Sadan G, et al: Unfractioned heparin produces vasodilatory action on human internal mammary artery by endothelium-dependent mechanisms. J Cardiovasc Pharmacol 2005; 45:114-119
12. Rønnestad A, Abrahamsen TG, Medbø S, et al: Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics 2005; 115:e269-e276
13. Shah PS, Kalyn A, Satodia P, et al: A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: The HIP (Heparin infusion for PCVC) study. Pediatrics 2007; 119:284-291